TWD
MIRM icon

True Wealth Design’s Mirum Pharmaceuticals MIRM Stock Holding History

True Wealth Design’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.2K Hold
70
– – ﹤0.01% 1139
2026
Q1 		$6.47K Hold
70
– – ﹤0.01% 1115
2025
Q4 		$5.53K Hold
70
– – ﹤0.01% 1047
2025
Q3 		$5.13K Hold
70
– – ﹤0.01% 1073
2025
Q2 		$3.56K Buy
70
+66
+1,650% +$2.94K ﹤0.01% 948
2025
Q1 		$181 Buy
+4
New +$189 ﹤0.01% 1994

Other funds holding MIRM

Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
SAM
Secure Asset Management Troy, Michigan $714M AUM 27.91% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
DT
Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return
EA
Ellsworth Advisors Hudson, Ohio $609M AUM 52.37% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return
NAM
NorthCrest Asset Manangement Plymouth, Minnesota $3.89B AUM 40.33% 1-Year Est. Return
JWS
Juncture Wealth Strategies Scottsdale, Arizona $384M AUM 27.62% 1-Year Est. Return
CIM
Contravisory Investment Management Norwell, Massachusetts $566M AUM 42.93% 1-Year Est. Return

True Wealth Design's MIRM Position: Q2 2026 in Review

True Wealth Design held its Mirum Pharmaceuticals (MIRM) position steady in Q2 2026 at 70 shares worth $8.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1139.

True Wealth Design first reported a position in MIRM in Q1 2025 and has held it in 6 quarters since. 22 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • True Wealth Design held 70 shares of Mirum Pharmaceuticals worth $8.2K as of Q2 2026.
  • True Wealth Design left its Mirum Pharmaceuticals share count unchanged in Q2 2026.
  • Mirum Pharmaceuticals made up ﹤0.01% of True Wealth Design's portfolio in Q2 2026, its #1139 holding.
  • True Wealth Design first reported a position in Mirum Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • 22 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on True Wealth Design's 13F filing for Q2 2026, filed 16 Jul 2026.